Natixis Advisors’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-66,708
Closed -$538K – 1590
2024
Q1
$538K Sell
66,708
-24,715
-27% -$219K ﹤0.01% 1372
2023
Q4
$908K Buy
91,423
+47,828
+110% +$375K ﹤0.01% 1233
2023
Q3
$348K Sell
43,595
-33,964
-44% -$341K ﹤0.01% 1421
2023
Q2
$853K Buy
77,559
+19,171
+33% +$197K ﹤0.01% 1201
2023
Q1
$603K Sell
58,388
-209,834
-78% -$2.47M ﹤0.01% 1261
2022
Q4
$2.95M Buy
268,222
+52,668
+24% +$677K 0.01% 828
2022
Q3
$3.35M Buy
215,554
+40,817
+23% +$898K 0.01% 738
2022
Q2
$4.01M Sell
174,737
-48,022
-22% -$1.03M 0.02% 714
2022
Q1
$5.49M Buy
222,759
+154,936
+228% +$3.5M 0.02% 654
2021
Q4
$1.85M Buy
+67,823
New +$2.37M 0.01% 970

Other funds holding DH

Natixis Advisors's DH Position: Q2 2024 in Review

Natixis Advisors sold out of Definitive Healthcare (DH) in Q2 2024, closing a stake of 66,708 shares — an estimated $538K sold.

Natixis Advisors first reported a position in DH in Q4 2021 and held it in 10 quarters. The position peaked at $5.49M in Q1 2022. 144 funds tracked by Wall St. Rank hold DH as of Q2 2024.

  • Natixis Advisors reported no remaining Definitive Healthcare position as of Q2 2024 after selling out during the quarter.
  • Natixis Advisors sold 66,708 Definitive Healthcare shares in Q2 2024, an estimated $538K.
  • Natixis Advisors first reported a position in Definitive Healthcare in Q4 2021 and held it in 10 quarters.
  • Natixis Advisors's Definitive Healthcare position peaked at $5.49M in Q1 2022.
  • 144 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2024.

Based on Natixis Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.